#1 Source for Hair Loss and Propecia: Hair Loss Starters Guide - Propecia - Avodart - Rogaine - Nizoral
Special Hairloss Topics: Hair Transplant Advice - Hair Replacement Advice - Female Hair Loss
X5 hair laser for hair loss
Ad: X5 hair laser for hair loss
Regrowth.com

Hair Loss Study Abstract: Five-year follow-up of patients with benign prostatic hyperplasia treated with finasteride.

Title
Five-year follow-up of patients with benign prostatic hyperplasia treated with finasteride.
Author
Geller J
Address
Mercy Hospital and Medical Center, San Diego, CA 92103-2180, USA.
Source
Eur Urol, 27: 4, 1995, 267-73
Abstract
In 18 of 55 original patients who completed 5 years of treatment with finasteride, significant reductions in prostate size were noted at 1 year and sustained thereafter. Symptom scores in these same patients were significantly improved or stable over the 5 years while maximal urinary flow rates were unchanged. Data from 15 of 18 other patients who dropped out of the study before 5 years showed changes in prostate size, symptom score and flow rates that were similar to those noted in patients treated for 5 years. No side effects were noted in this study except for sexual dysfunction, which occurred in less than 5% of the patients. With few exceptions, finasteride appears to arrest the process of BPH over a 5 year period as indicated by sustained reductions in prostate size accompanied by either symptomatic improvement or stability in all other patients.
Language of Publication
English
Unique Identifier
95385710
content2

Location:
Unknown

Location wrong? Click here
What's This?

Web
regrowth.com
Order Spectral DNC, Propecia and Avodart at hair2go.com
Ad: Propecia, Avodart, Spectral DNC and more!

More Info: Home | About Regrowth.com | How to Advertise | Privacy Policy | Advertising Policy | Contact Us
Site Map | Copyright © 2007 The Regrowth Network. All rights reserved. Legal Disclaimer

Other Cool Sites: Hair Loss Treatments - Body for Life Tracker - MedSpert

Propecia ® is a registered trademark of Merck. Avodart ® is a registered trademark of GlaxoSmithKline.
Rogaine ® is a registered trademark of Pfizer. Nizoral ® is a registered trademark of McNeil Consumer & Specialty Pharmaceuticals.